A model of an empagliflozin molecule is placed in a time capsule at the groundbreaking ceremony for Boehringer Ingelheim's Chemical Innovation Plant. From L-R: Malu Dreyer, Minister President of Rhineland-Palatinate; Boehringer Ingelheim chairman Hubertus von Baumbach; and German Chancellor Olaf Scholz (Sebastian Gollnow/picture-alliance/dpa/AP Images)
May 2, 2023 03:00 PM EDT
R&D
Manufacturing

Boehringer In­gel­heim to con­struct a $300M+ fa­cil­i­ty at its HQ

Tyler Patchen

News Reporter

Boehringer In­gel­heim plans to make a ma­jor in­vest­ment in­to man­u­fac­tur­ing chem­i­cals and ac­tive phar­ma­ceu­ti­cal in­gre­di­ents close to home.

The Ger­man phar­ma on Tues­day broke ground …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump an­nounces picks for FDA, CDC; No­var­tis seeks bolt-on deals, rais­es guid­ance; RFK Jr., Elon Musk may find ...

For CDC, Trump picks Dave Wel­don, a for­mer con­gress­man who pushed for vac­cine in­jury claims

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times